Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: Ovarian Neoplasms and XRCC2[original query] |
---|
Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Feb 14 (2): 319-23. Webb Penelope M, Hopper John L, Newman Beth, Chen Xiaoqing, Kelemen Livia, Giles Graham G, Southey Melissa C, Chenevix-Trench Georgia, Spurdle Amanda |
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Dec 16 (12): 2557-65. Beesley Jonathan, Jordan Susan J, Spurdle Amanda B, Song Honglin, Ramus Susan J, Kjaer Suzanne Kruger, Hogdall Estrid, DiCioccio Richard A, McGuire Valerie, Whittemore Alice S, Gayther Simon A, Pharoah Paul D P, Webb Penelope M, Chenevix-Trench Georgia, , , |
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British journal of cancer 2009 Jan 100 (2): 412-20. Pearce C L, Near A M, Van Den Berg D J, Ramus S J, Gentry-Maharaj A, Menon U, Gayther S A, Anderson A R, Edlund C K, Wu A H, Chen X, Beesley J, Webb P M, Holt S K, Chen C, Doherty J A, Rossing M A, Whittemore A S, McGuire V, DiCioccio R A, Goodman M T, Lurie G, Carney M E, Wilkens L R, Ness R B, Moysich K B, Edwards R, Jennison E, Kjaer S K, Hogdall E, Hogdall C K, Goode E L, Sellers T A, Vierkant R A, Cunningham J M, Cunningham J C, Schildkraut J M, Berchuck A, Moorman P G, Iversen E S, Cramer D W, Terry K L, Vitonis A F, Titus-Ernstoff L, Song H, Pharoah P D P, Spurdle A B, Anton-Culver H, Ziogas A, Brewster W, Galitovskiy V, Chenevix-Trench G, , |
Germline mutation in the RAD51B gene confers predisposition to breast cancer. BMC cancer 2013 13 (1): 484. Golmard Lisa, Caux-Moncoutier Virginie, Davy Grégoire, Al Ageeli Essam, Poirot Brigitte, Tirapo Carole, Michaux Dorothée, Barbaroux Catherine, d'Enghien Catherine Dubois, Nicolas André, Castéra Laurent, Sastre-Garau Xavier, Stern Marc-Henri, Houdayer Claude, Stoppa-Lyonnet Dominiq |
Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility. Molecular biology reports 2013 Jan . Mohamed FZ, Hussien YM, Albakry MM, Mohamed RH, Said NM |
RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study. PloS one 2012 7 (12): e52374. Le Calvez-Kelm Florence, Oliver Javier, Damiola Francesca, Forey Nathalie, Robinot Nivonirina, Durand Geoffroy, Voegele Catherine, Vallée Maxime P, Byrnes Graham, Registry Breast Cancer Family, Hopper John L, Southey Melissa C, Andrulis Irene L, John Esther M, Tavtigian Sean V, Lesueur Fabien |
The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5797-804. Shi Shujing, Qin Lingyan, Tian Mengqiu, Xie Mao, Li Xiaoxue, Qi Chenglin, Yi Xia |
Impact of XRCC2 Arg188His polymorphism on cancer susceptibility: a meta-analysis. PloS one 2014 9 (3): e91202. He Yazhou, Zhang Yuanchuan, Jin Chengwu, Deng Xiangbing, Wei Mingtian, Wu Qingbin, Yang Tinghan, Zhou Yanhong, Wang Ziqia |
An association between the -41657 C/T polymorphism of X-ray repair cross-complementing 2 (XRCC2) gene and ovarian cancer. Medical oncology (Northwood, London, England) 2014 Dec 31 (12): 300. Michalska Magdalena M, Samulak Dariusz, Smolarz Bea |
The Arg188His polymorphism in the XRCC2 gene and the risk of cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Apr 35 (4): 3541-9. Zhang Yonggang, Wang Haichuan, Peng Yuanling, Liu Yuqi, Xiong Tianyuan, Xue Pei, Du Lia |
Arg188His polymorphism in the XRCC2 gene and the risk of ovarian cancer: a meta-analysis. Genetics and molecular research : GMR 2015 14 (3): 10808-15. Zhai M, Wang Y, Jiang M |
Screening of HELQ in breast and ovarian cancer families. Familial cancer 2015 Sep . Pelttari Liisa M, Kinnunen Laura, Kiiski Johanna I, Khan Sofia, Blomqvist Carl, Aittomäki Kristiina, Nevanlinna He |
RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families. SpringerPlus 2015 4 92. Pelttari Liisa M, Kiiski Johanna I, Ranta Salla, Vilske Sara, Blomqvist Carl, Aittomäki Kristiina, Nevanlinna He |
Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations. Human mutation 2016 Feb . Caminsky Natasha G, Mucaki Eliseos J, Perri Ami M, Lu Ruipeng, Knoll Joan H M, Rogan Peter |
Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer. Oncotarget 2016 Nov . Zhang Wei, Zhang Zhif |
Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women. Experimental and molecular pathology 2016 Jan . Michalska Magdalena M, Samulak Dariusz, Romanowicz Hanna, Jab?o?ski Filip, Smolarz Bea |
Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis. Asian Pacific journal of cancer prevention : APJCP 2017 07 18 (7): 1743-1749. Kamali Mahdieh, Hamadani Sedigheh, Neamatzadeh Hossein, Mazaheri Mahta, Zare Shehneh Masoud, Modaress Gilani Mitra, Haghighi Fatem |
Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma. Cancer research 2017 Jun . Rivera Barbara, Di Iorio Massimo, Frankum Jessica, Nadaf Javad, Fahiminiya Somayyeh, Arcand Suzanna L, Burk David L, Grapton Damien, Tomiak Eva, Hastings Valerie, Hamel Nancy, Wagener Rabea, Aleynikova Olga, Giroux Sylvie, Hamdan Fadi F, Dionne-Laporte Alexandre, Zogopoulos George, Rousseau Francois, Berghuis Albert M, Provencher Diane, Rouleau Guy A, Michaud Jacques L, Mes-Masson Anne-Marie, Majewski Jacek, Bens Susanne, Siebert Reiner, Narod Steven A, Akbari Mohammad R, Lord Christopher J, Tonin Patricia N, Orthwein Alexandre, Foulkes William |
Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53. International journal of cancer 2017 08 141 (4): 750-756. Lolas Hamameh Suhair, Renbaum Paul, Kamal Lara, Dweik Dima, Salahat Mohammad, Jaraysa Tamara, Abu Rayyan Amal, Casadei Silvia, Mandell Jessica B, Gulsuner Suleyman, Lee Ming K, Walsh Tom, King Mary-Claire, Levy-Lahad Ephrat, Kanaan Moe |
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers. European journal of human genetics : EJHG 2017 Dec 25 (12): 1345-1353. Golmard Lisa, Castéra Laurent, Krieger Sophie, Moncoutier Virginie, Abidallah Khadija, Tenreiro Henrique, Laugé Anthony, Tarabeux Julien, Millot Gael A, Nicolas André, Laé Marick, Abadie Caroline, Berthet Pascaline, Polycarpe Florence, Frébourg Thierry, Elan Camille, de Pauw Antoine, Gauthier-Villars Marion, Buecher Bruno, Stern Marc-Henri, Stoppa-Lyonnet Dominique, Vaur Dominique, Houdayer Clau |
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population. Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings. Journal of cancer research and clinical oncology 2018 10 144 (12): 2495-2513. Bonache Sandra, Esteban Irene, Moles-Fernández Alejandro, Tenés Anna, Duran-Lozano Laura, Montalban Gemma, Bach Vanessa, Carrasco Estela, Gadea Neus, López-Fernández Adrià, Torres-Esquius Sara, Mancuso Francesco, Caratú Ginevra, Vivancos Ana, Tuset Noemí, Balmaña Judith, Gutiérrez-Enríquez Sara, Diez Orla |
Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer. Pathology oncology research : POR 2019 Feb . Smolarz Beata, Michalska Magdalena M, Samulak Dariusz, Romanowicz Hanna, Wójcik Lui |
Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk. Archives of medical science : AMS 2020 16 (3): 682-691. Yuan Cunzhong, Liu Xiaoyan, Li Rongrong, Yan Shi, Kong Beih |
Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition. Genes, chromosomes & cancer 2020 Oct . Cavaillé Mathias, Uhrhammer Nancy, Privat Maud, Ponelle-Chachuat Flora, Gay-Bellile Mathilde, Lepage Mathis, Molnar Ioana, Viala Sandrine, Bidet Yannick, Bignon Yves-Je |
Association between RAD51, XRCC2 and XRCC3 gene polymorphisms and risk of ovarian cancer: a case control and an in silico study. Molecular biology reports 2021 Jun . Gowtham Kumar G, Paul Solomon Franklin Durairaj, Martin Jovita, Manickavasagam M, Sundersingh Shirley, Ganesan Nalini, Ramya R, Usha Rani G, Andrea Mary Franc |
- Page last reviewed:Feb 1, 2024
- Content source: